Literature DB >> 10430185

Human mammary epithelial cells rapidly exchange empty EGFR between surface and intracellular pools.

P M Burke1, H S Wiley.   

Abstract

Binding of ligand to the epidermal growth factor receptor (EGFR) initiates a series of processes including activation of the intrinsic EGFR tyrosine kinase, receptor autophosphorylation, and the assembly of active signaling complexes at the plasma membrane. Concomitantly, receptor trafficking is initiated, and the receptor is ultimately delivered to the lysosome, where it is degraded. Virtually all studies on EGFR trafficking have used fibroblasts and transformed cells. Because EGFR exerts a potent effect on the physiology of epithelial cells, we examined the regulation of EGFR activity and trafficking in nontransformed human mammary epithelial cells (HMEC). We found that HMEC that displayed a luminal phenotype were largely unresponsive to EGF and maintained a majority of their EGFR at the cell surface. In contrast, HMEC with a basal phenotype were highly responsive to EGF and, at steady state in the absence of exogenous ligand, distributed empty EGFR into intracellular pools. Maintenance of the intracellular pools was a direct consequence of specific and rapid endocytosis of the empty EGFR. The trafficking pattern was EGFR specific, used coated pits, and did not require receptor tyrosine kinase activity. Such an mechanism redistributes EGFR signaling potential among different membrane domains and into vesicles with unique biochemical microenviroments. In addition, our data show that EGFR endocytosis can be regulated in the absence of ligand binding and receptor activation in a cell-type-specific manner.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430185     DOI: 10.1002/(SICI)1097-4652(199909)180:3<448::AID-JCP16>3.0.CO;2-8

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  14 in total

1.  Scale-up of a physiologically-based pharmacokinetic model to predict the disposition of monoclonal antibodies in monkeys.

Authors:  Patrick M Glassman; Yang Chen; Joseph P Balthasar
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-09-12       Impact factor: 2.745

Review 2.  Endocytosis of receptor tyrosine kinases.

Authors:  Lai Kuan Goh; Alexander Sorkin
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-05-01       Impact factor: 10.005

3.  Conservation of protein abundance patterns reveals the regulatory architecture of the EGFR-MAPK pathway.

Authors:  Tujin Shi; Mario Niepel; Jason E McDermott; Yuqian Gao; Carrie D Nicora; William B Chrisler; Lye M Markillie; Vladislav A Petyuk; Richard D Smith; Karin D Rodland; Peter K Sorger; Wei-Jun Qian; H Steven Wiley
Journal:  Sci Signal       Date:  2016-07-12       Impact factor: 8.192

4.  Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking.

Authors:  P Burke; K Schooler; H S Wiley
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

5.  Physiologically-based pharmacokinetic modeling to predict the clinical pharmacokinetics of monoclonal antibodies.

Authors:  Patrick M Glassman; Joseph P Balthasar
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-07-04       Impact factor: 2.745

6.  Analysis of EGF Receptor Endocytosis Using Fluorogen Activating Protein Tagged Receptor.

Authors:  Mireia Perez Verdaguer; Mads B Larsen; Marcel P Bruchez; Simon C Watkins; Alexander Sorkin
Journal:  Bio Protoc       Date:  2019-12-20

7.  Mechanism of p38 MAPK-induced EGFR endocytosis and its crosstalk with ligand-induced pathways.

Authors:  Mireia Perez Verdaguer; Tian Zhang; Joao A Paulo; Steven Gygi; Simon C Watkins; Hiroaki Sakurai; Alexander Sorkin
Journal:  J Cell Biol       Date:  2021-05-25       Impact factor: 10.539

8.  Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.

Authors:  Laura N Burga; Hai Hu; Ashish Juvekar; Nadine M Tung; Susan L Troyan; Erin W Hofstatter; Gerburg M Wulf
Journal:  Breast Cancer Res       Date:  2011-03-11       Impact factor: 6.466

9.  Modulation of integrin-linked kinase (ILK) expression in human oesophageal squamous cell carcinoma cell lines by the EGF and TGFbeta1 growth factors.

Authors:  Glenn A Driver; Robin B Veale
Journal:  Cancer Cell Int       Date:  2006-04-27       Impact factor: 5.722

Review 10.  Cell surface receptors for signal transduction and ligand transport: a design principles study.

Authors:  Harish Shankaran; Haluk Resat; H Steven Wiley
Journal:  PLoS Comput Biol       Date:  2007-04-20       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.